ISPVX | VSCPX | ISPVX / VSCPX | |
Total Expense Ratio | 0.77 | 0.03 | 2,567% |
Annual Report Gross Expense Ratio | 0.99 | 0.03 | 3,300% |
Fund Existence | 11 years | 15 years | - |
Gain YTD | 2.035 | 1.452 | 140% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 369M | 148B | 0% |
Annual Yield % from dividends | 0.41 | 1.42 | 29% |
Returns for 1 year | 13.14 | 12.26 | 107% |
Returns for 3 years | 15.29 | 37.96 | 40% |
Returns for 5 years | 22.87 | 69.56 | 33% |
Returns for 10 years | 12.49 | 109.40 | 11% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
CPAI | 36.70 | 0.37 | +1.02% |
Counterpoint Quantitative Equity ETF | |||
FLN | 20.33 | 0.20 | +0.99% |
First Trust Latin America AlphaDEX® ETF | |||
GOF | 14.95 | 0.05 | +0.34% |
Guggenheim Strategic Opportunities Fund | |||
FINS | 13.12 | 0.04 | +0.31% |
Angel Oak Financial Strategies Income Term Trust | |||
LFSC | 24.66 | N/A | N/A |
F/m Emerald Life Sciences Innovation ETF |